FDA nod for Xdemvy, first treatment for eyelid disease, Demodex blepharitis

The US Food and Drug Administration (FDA) yesterday approved Xdemvy (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis …